Lumida
/ALHC
⌘K
Alignment Healthcare Inc

Alignment Healthcare Inc

ALHC
$12.61USD-1.18%-0.15 today

MARKET CAP

2.6B

P/E (TTM)

140.1x

FWD P/E

DAY RANGE

$12 – $13

52W RANGE

$12
$25

AI Summary

Stalk
TrimMedium

ALHC remains entrenched in a Stage 4 decline with supply dominance reinforced by a Lower Highs & Lower Lows pattern. Price trades below all key EMAs and DMAs without signs of reversal, and short-term timing is neutral, warranting trims into rallies toward declining EMAs rather than chasing declines.

  • Q2 membership reached 294,100 (+31% YoY) and revenue hit $1.3B (+32% YoY)
  • Adjusted EBITDA rose to $68M (+48% YoY) with a 5.1% margin
  • Negative earnings yield and low profitability raise valuation concerns
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.2B$1.4B$1.8B$2.7B$3.9B
YoY %+22.6%+25.8%+48.4%+46.4%
P / Sales2.1x1.5x0.9x0.8x1.0x
EV / Sales1.9x1.5x1.0x0.9x1.1x
Gross Profit, Adj.$1.2B$1.4B$178.3M$265.1M$451.6M
YoY %+22.6%-87.5%+48.6%+70.4%
Margin %100.0%100.0%9.9%9.9%11.5%
EV / Gross Profit1.9x1.5x10.2x9.0x9.3x
EBITDA, Adj.$-161.8M$-113.8M$-128.8M$-106.1M$8.2M
YoY %+29.7%-13.3%+17.6%+107.8%
Margin %-13.9%-7.9%-7.2%-4.0%0.2%
EV / EBITDA-14.1x-18.4x-14.1x-22.6x512.7x
EBIT$-177.8M$-131.2M$-150.5M$-133.2M$-22.2M
YoY %+26.2%-14.7%+11.5%+83.3%
Margin %-15.2%-9.2%-8.4%-5.0%-0.6%
EV / EBIT-12.8x-15.9x-12.0x-18.0x-189.7x
Net Income$-195.3M$-149.5M$-148.0M$-128.0M$-724,000
YoY %+23.4%+1.0%+13.5%+99.4%
Net Margin-16.7%-10.4%-8.2%-4.8%-0.0%
EPS (GAAP)-$1.14-$0.83-$0.79-$0.67
YoY %+27.2%+4.8%+15.2%